Related Experiment Video
Updated: Feb 6, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
Emanuela Martino1, Giuseppe Casamassima2, Sonia Castiglione2
1Department of Earth and Environmental Sciences, University of Pavia, Via S. Epifanio 14, 27100 Pavia, Italy.
Abstract:
Cancer still represents a "nightmare" worldwide, causing annually millions of victims. Several antiproliferative molecules are currently used as drugs market and offer a pharmaceutical opportunity for attenuating and treating tumor manifestations. In this context, natural sources have a relevant role, since they provide the 60% of currently-used anticancer agents. Among the numerous natural products, acting via different mechanisms of action, microtubule-targeting agents (MTAs) have a high therapeutic potential, since they disrupt the abnormal cancer cell growth, interfering with the continuous mitotic division. Vinca alkaloids (VAs) are the earliest developed MTAs and approved for clinical use (Vincristine, Vinblastine, Vinorelbine, Vindesine, and Vinflunine) as agents in the treatment of hematological and lymphatic neoplasms. Here, we review the state-of-art of VAs, discussing their mechanism of action and pharmacokinetic properties and highlighting their therapeutic relevance and toxicological profile. Additionally, we briefly disclosed the technological approaches faced so far to ameliorate the pharmacological properties, as well as to avoid the drug resistance. Lastly, we introduced the recent advances in the discovery of new derivatives.
Insights
Vinca alkaloids (VAs), derived from natural sources, are crucial microtubule-targeting agents (MTAs) for cancer treatment. This review covers their mechanisms, properties, and advancements in overcoming drug resistance.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- Cancer remains a significant global health burden, necessitating effective antiproliferative therapies.
- Natural products are a vital source of anticancer agents, contributing to 60% of current drugs.
- Microtubule-targeting agents (MTAs) show high therapeutic potential by disrupting cancer cell division.
Purpose of the Study:
- To provide a comprehensive review of Vinca alkaloids (VAs), a key class of MTAs.
- To discuss the mechanism of action, pharmacokinetics, therapeutic relevance, and toxicological profile of VAs.
- To explore technological strategies for improving VA properties and overcoming drug resistance, including new derivative discovery.
Main Methods:
- Literature review of existing research on Vinca alkaloids.
- Analysis of VAs' mechanism of action, focusing on interference with mitotic division.
- Examination of pharmacokinetic properties, therapeutic efficacy, and toxicological data.
Main Results:
- Vinca alkaloids are among the earliest developed and clinically approved MTAs for treating hematological and lymphatic neoplasms.
- VAs exert their antiproliferative effects by disrupting microtubule dynamics, crucial for cancer cell mitosis.
- The review highlights the established therapeutic value alongside the toxicological considerations of VAs.
Conclusions:
- Vinca alkaloids remain essential in cancer chemotherapy, particularly for hematological malignancies.
- Ongoing research focuses on enhancing VA pharmacological profiles and circumventing drug resistance through technological innovations.
- The discovery of novel VA derivatives holds promise for future cancer treatment strategies.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Influence of Parents and Peers on Identity
Parental Influence on Identity Development
Parents serve as primary guides and managers in an adolescent's life, offering support instrumental in decision-making and personal growth....
Subviral Agents
Air-entraining Agents
Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...

